Gorrab A, Pagano A, Ayed K, Chebil M, Derouiche A, Kovacic H, et al
Bottom line: Weight loss peptides can be safe so long as they are part of a supervised treatment plan
If you experience any suspected side effects from Rybelsus, you can report these via the MHRA Yellow Card scheme at yellowcard
These serious side effects can occur with tirzepatide
Peptide Vials (BPC-157, 10 mg each): 8 weeks 3 vials (25.2 mg used) 12 weeks 5 vials (42 mg used) 16 weeks 6 vials (58.8 mg used) Insulin Syringes (U-100): Per week: 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syringes 16 weeks: 112 syringes Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution
First Large Population Study Links GLP-1 Drugs to Hair Loss Until now, evidence linking GLP-1 drugs to hair loss came mostly from scattered case reports and informal complaints to the FDA, which said in 2023 it was looking into a possible safety concern